Is your child currently experiencing moderate to severe CD flare-ups? Local Crohn’s disease (CD) clinical research is testing a potential new medication to see if it may reduce swollen joints, failure to thrive, bloody stool, weight loss, and/or anemia associated with moderate to severe CD.
If you’re concerned about how moderate to severe CD affects your child’s life, find out more about the Crohn’s disease (CD) clinical research.
Your child may be eligible for one of the GI studies if they are 2‒17 years of age, have been diagnosed with moderate to severe UC or CD, and have previously received treatment for UC or CD that has not worked.
By joining the GI studies, your child may receive:
- Compensation for study-related time
- Reimbursement for study-related travel
- Study-related care from local doctors
- Study medication at no cost
Health insurance is not required to take part.
Find out if your child qualifies.
